EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links


[Á¦3ȸ ¼øõ¸¸ ³»½Ã°æ ¼¼¹Ì³ª (2015)]

2015³â 5¿ù 30ÀÏ Á¦ 3ȸ ¼øõ¸¸ ³»½Ã°æ ½ÉÆ÷Áö¾ö¿¡ ´Ù³à¿Ô½À´Ï´Ù. ¼øõ½ÃÀÇ»çÇùȸÀåÀ̽ŠÀ§¾ØÀå¼­³»°ú ¼­Á¾¿Á ¿øÀå´Ô²²¼­ ÁÖµµÀûÀ¸·Î À̲ø°í ÀÖ´Â Çà»çÀÔ´Ï´Ù. °ÅÀÇ È¥ÀÚ ¸¸µé¾î ³ª°¡´Â ½ÉÆ÷Áö¾öÀÔ´Ï´Ù. ¼±»ý´ÔÀÇ ³ë°í¿¡ °¨»çµå¸³´Ï´Ù


µ¹¾Æ¿À´Â ºñÇà±â¿¡¼­ ¹Ù¶óº» ¿©¼ö ¾Õ¹Ù´Ù


1. °í·ÉȯÀÚÀÇ ³»½Ã°æ (¼º±Õ°üÀÇ´ë ÀÌÁØÇà)


2. ±â´É¼º ÀåÁúȯÀÇ ±âÀü°ú Ä¡·á (¿¬¼¼´ëÇб³ ¹ÚÈ¿Áø ±³¼ö´Ô)

¿¬¼¼´ëÇб³ ¹ÚÈ¿Áø ±³¼ö´Ô²²¼­´Â '±â´É¼º ÀåÁúȯÀÇ ±âÀü°ú Ä¡·á'¶ó´Â Á¦¸ñÀ¸·Î ¼¼·ÎÅä´Ñ°ú Àå³»°¡½º, ¼¼±Õ¿¡ ´ëÇÏ¿© Ư°­À» Çϼ̽À´Ï´Ù. °ú°ÅÀÇ symptom-based therapy¿¡¼­ hypothesis-based therapy·Î paradigm shift°¡ µÇ¾ú½À´Ï´Ù.

¼¼·ÎÅä´ÑÀº ¿¬µ¿¹Ý»ç¿¡ °ü¿©ÇÕ´Ï´Ù. 7°³ÀÇ ¼ö¿ëü Áß ¼ÒÈ­±â¿¡¼­´Â 3, 4°¡ °ü¿©µË´Ï´Ù.

5-HT4 ¼ö¿ëü agonist´Â (1) neurogenesis, (2) prokinetics, (3) anti-inflammatory actionÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

°¡½º Áß hydrogenÀº IBS-D¿¡ °ü¿©ÇÏ°í methaneÀº IBS-C¿Í °ü¿©µË´Ï´Ù. MethaneÀº segmental nonpropagating contractionÀ» ÃËÁøÇϱ⠶§¹®ÀÔ´Ï´Ù. º¯ºñ ȯÀÚ¿¡¼­ methane »ý¼º ¼¼±ÕÀÇ ºñÀ²ÀÌ ¸¹Àºµ¥, ȯÀÚ°¡ bloatingÁõ»óÀÌ ÀÖÀ¸¸é Ç×»ýÁ¦ rifaximinÀÌ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

Probiotics Áß ºñ¿ÀÆúÀº IBS ȯÀÚÀÇ »îÀÇ ÁúÀ» °³¼±ÇÏ¿´½À´Ï´Ù. ½ºÆ®·¹½º°¡ ÀÖÀ¸¸é CRH°¡ ³ª¿À´Âµ¥ gastric emptyingÀ» ´ÊÃß°í bowel movement´Â Áõ°¡½ÃÄÑ overlap syndromeÀ» ÀÏÀ¸Åµ´Ï´Ù. Psychotropic agent´Â neurotrophic effect¿Í neuroprotective effect¸¦ °¡Áö°í ÀÖ½À´Ï´Ù.


3. Gastric malignant lesions observed in a single clinic (Ç÷¯½º³»°ú ¾È¿ëȯ ¿øÀå´Ô)

Ç÷¯½º ³»°ú ¾È¿ëȯ ¼±»ý´Ô²²¼­ ÀÏÂ÷ÀÇ·á±â°ü¿¡¼­ ¹ß°ßµÈ ´Ù¾çÇÑ À§¾ÏÀ» º¸¿©Áּ̽À´Ï´Ù. À§°¢ Á÷ÇϺΠ¼Ò¸¸Àº ÀÇ¿ÜÀÇ blind areaÀ̹ǷΠÀÛÀº º´¼Ò¸¦ ³õÄ¥ ¼ö ÀÖÀ¸¹Ç·Î ÁÖÀÇÇØ¾ß ÇÒ °Í °°½À´Ï´Ù. FundusÀÇ greater curvatureµµ ¸¶Âù°¡ÁöÀÔ´Ï´Ù. Ç÷¯½º ³»°ú¿¡¼­ Áö³­ 5³â°£ ¹ß°ßÇÑ 141¿¹ÀÇ À§¾Ï Áß 7.8%ÀÎ 11¸íÀÌ 40¼¼ ÀÌÇÏ¿´´Ù°í ÇÕ´Ï´Ù. °³ÀÎ º´¿ø¿¡¼­ ¹ß°ßµÈ À§¾Ï¿¡ ´ëÇÑ ÀÌó·³ »ó¼¼ÇÑ ÀڷḦ º¼ ¼ö ÀÖ´Ù´Ï ³î¶ó¿î ÀÏÀÔ´Ï´Ù.

¾È¿ëȯ ¼±»ý´ÔÀº À§Ã¼»óºÎ¿Í fundusÀÇ Á¡¸·ÇÏÇ÷°üÀÌ À¯³­È÷ engorgedµÇ¾î ÀÖ¾î ÃÊÀ½Æİ˻縦 ±ÇÀ¯ÇÏ¿© ³»½Ã°æ¿¡¼­´Â º¸ÀÌÁö ¾Ê¾Ò´ø exophytic growing GIST (8cm)¸¦ Áø´ÜÇÑ ¿¹µµ º¸¿©Áּ̽À´Ï´Ù. À§¾ÏÀ¸·Î total gastrectomy¸¦ ¹ÞÀº ȯÀÚÀÇ jejunum ±íÀº °÷¿¡¼­ À§¾Ï Àç¹ßº´¼Ò¸¦ ¹ß°ßÇÑ ¿¹¿¡¼­´Â anastomosis site¸¸ º¸Áö ¸»°í ±íÀº °÷±îÁö ºÁ¾ß ÇÑ´Ù´Â Á¡À» °­Á¶ÇØÁּ̽À´Ï´Ù.

ÁÂÀåÀ̴̼ø Á¶¼±´ëÇб³ ¹ÚÂù±¹ ±³¼ö´Ô²²¼­ »ï¼º¼­¿ïº´¿øÀÇ ¿À·¡µÈ ¿¬±¸ °á°ú¸¦ ¼Ò°³ÇØÁּ̽À´Ï´Ù. ÇöÀç´Â °Ç±¹´ëÇб³¿¡¼­ ¸ÍÈ°¾àÁßÀÎ À̼±¿µ ¼±»ý´ÔÀÌ Á¦ 1ÀúÀÚ·Î EJSO¿¡ 2005³â ¹ßÇ¥ÇÑ ³í¹®À̸ç, ¹ÚÂù±¹ ¼±»ý´Ô²²¼­ ¾ð±ÞÇϽŠ³»¿ëÀº ¾Æ·¡ Ç¥ÀÔ´Ï´Ù. ³»½Ã°æÀ¸·Î local recur¸¦ ¹ß°ßÇÏ¿©µµ ´ëºÎºÐ systemic recur¸¦ ÇÔ²² °¡Áö°í ÀÖ´Ù´Â °á°ú¿´½À´Ï´Ù.

°ü·ÃÇÏ¿© EJSO 2005 ³í¹®ÀÇ ³»¿ëÀ» ¼Ò°³ÇÏ¿´´ø EndoTODAYÀÇ postoperative.htmlÀÇ ³»¿ëÀ» ÀϺΠ¿Å±é´Ï´Ù.


À§¾Ï ¼ö¼ú ÈÄ ¹®ÇպΠÇùÂøÀÌ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ total gastrectomy ÈÄ ½Äµµ¿Í ¼ÒÀåÀÇ ¿¬°áºÎ°¡ membraneousÇÏ°Ô Á¼¾ÆÁö´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÃÖ±Ù¿¡´Â ¸¹ÀÌ ÁÙ¾úÁö¸¸ 2005³â¿¡ ¹ßÇ¥µÈ »ï¼º¼­¿ïº´¿øÀÇ ÀڷḦ º¸¸é total gastrectomyÈÄ 8-9% ÀüÈÄ¿¡¼­ stricture°¡ ¹ß»ýÇÏ¿´½À´Ï´Ù.

¼ö¼úÇÑ È¯ÀÚ¿¡°Ô ¹Ì¸® obstruction Áõ»óÀ» ¼³¸íÇØ ÁÖ´Â °ÍÀº ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °£È¤ obstruction Áõ»óÀ» ¼ö¼ú ÈÄ ´ç¿¬È÷ ¹ß»ýÇÒ ¼ö ÀÖ´Â º¯È­·Î »ý°¢ÇÏ¿© ¸î ´ÞÀ̳ª Âü°í Áö³»´Â ȯÀÚµéÀ» ¸¸³¯ ¼ö ÀÖ½À´Ï´Ù.


Lee SY, Lee JH et al. EJSO 2005;31:265-269

Anastomosis siteÀÇ benign postoperative stricture°¡ ÈçÇÏÁö¸¸ µå¹°°Ô local recurrenceµµ °¡´ÉÇÕ´Ï´Ù. Benign stricture´Â ¼ö¼ú Á÷ÈĺÎÅÍ ¼ö°³¿ù À̳»¿¡ È£¹ßÇÏ°í 1³â ÀÌÈÄ¿¡ ¹ß»ýµÇ´Â °æ¿ì´Â µå¹´´Ï´Ù. ¹Ý¸é À§¾ÏÀÇ local recurrence¿¡ ÀÇÇÑ stricture´Â À§¾Ï ¼ö¼ú ¹Ý³â °æºÎÅÍ 2-3³â »çÀÌ¿¡ ¹ß°ßµÇ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ÀÏÂï ¹ß°ßµÇ¸é benign, ´Ê°Ô ¹ß°ßµÇ¸é malignancy¶ó´Â °æÇâÀÔ´Ï´Ù.


Lee SY, Lee JH et al. EJSO 2005;31:265-269

¹®ÇպΠÁÖÀ§ÀÇ Àç¹ßÀº ¹®ÇպΠ¼Ò¸¸Ãø¿¡ ¸¹À¸¸ç, ¹®ÇպΠÁÖÀ§ Á¡¸·ÀÇ °áÀý»ó À¶±â³ª Á¡¸· ºñÈÄ·Î ³ªÅ¸³¯ ¼ö ÀÖ½À´Ï´Ù. ¼ö¼ú ÈÄ¿¡´Â ¹®ÇÕ ºÎÀ§ÀÇ ºÎÁ¾°ú ¹ßÀû, ÀÜÁ¸ÇÏ´Â ºÀÇÕ»ç ÁÖº¯À¸·Î ¿°Áõ ¹× ºÎºÐÀûÀÎ ±Ë¾ç µîÀº ÀÜÀ§¾Ï ¶Ç´Â ¾ÏÀÇ Àç¹ß°ú È¥µ·µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÚ¼¼È÷ °üÂûµÇ°í Á¶±ÝÀÌ¶óµµ ÀÌ»óÇϸé Á¶Á÷°Ë»ç¸¦ ÇÏ´Â ¼ö ¹Û¿¡ ¾ø½À´Ï´Ù. ¾Æ·¡´Â ¼ö³â Àü »ï¼º¼­¿ïº´¿øÀÇ ³í¹®¿¡ ½Ç·È´ø Àç¹ß¿¹µéÀÔ´Ï´Ù.


Lee SY, Lee JH et al. EJSO 2005;31:265-269

Benign post-op stricture´Â ¼ö¼ú ÈÄ 4-8°³¿ù¿¡ ¹ß»ýÇÕ´Ï´Ù. 1³â ÀÌÈÄ¿¡ ¹ß°ßµÈ ÇùÂøÀº ´ëºÎºÐ ±¹¼ÒÀç¹ßÀÔ´Ï´Ù. µû¶ó¼­ total gastrectomyÈÄ anastomosis site stenosis·Î ³»¿øÇÑ È¯ÀÚ¿¡¼­ °¡Àå ¸ÕÀú È®ÀÎÇÒ °ÍÀº ¼ö¼ú ½ÃÁ¡ÀÔ´Ï´Ù. ¼ö¼úÇÑÁö 1³â ÀÌ»ó °æ°úÇÏ¿´À¸¸é ´ëºÎºÐ local recurÀÔ´Ï´Ù. °Ô´Ù°¡ ¼ö¼ú ´ç½Ã º´±â°¡ ³ô¾Ò´Ù¸é °ÅÀÇ Æ²¸²¾ø½À´Ï´Ù. ±×·¯³ª ¿ªÀº ¼º¸³ÇÏÁö ¾Ê½À´Ï´Ù. 1³â ¹Ì¸¸À̶ó°í ¸ðµÎ benign post-op stenosisÀÎ °ÍÀº ¾Æ´Õ´Ï´Ù. Á¶±ÝÀ̶ó°í Àǽɽº·¯¿ì¸é ¹Ù·Î dilatationÀ» ÇÒ °ÍÀÌ ¾Æ´Ï°í Á¶Á÷°Ë»ç¸¦ ÇØ¾ß ÇÕ´Ï´Ù.


4. CBD stone with biliary parasite (¼º°¡·Ñ·Îº´¿ø ±èµµÇö °úÀå´Ô)

EST·Î µ¹À» Á¦°ÅÇÑ ÈÄ balloon sweepÇÏ¿´´Âµ¥ °£ÈíÃæÀ¸·Î ÃßÁ¤µÇ´Â ±â»ýÃæÀÌ ³ª¿Ô½À´Ï´Ù. (1) ¹Î¹°°í±â¸¦ ¸ÔÁö ¾ÊÀº ºÐÀÌ¶óµµ Á¶¸®°úÁ¤¿¡¼­ ¿Å±æ ¼ö ÀÖÀ¸¹Ç·Î Ä®À» 30ÃÊ ÀÌ»ó ²ú´Â ¹°¿¡ ´ã±×´Â °ÍÀÌ ÁÁ°Ú°í, (2) ¹Î¹°°í±â »ý½ÄÀ» ÁÖº¯¿¡ ±ÇÇÏÁö ¸»ÀÚ°í Çϼ̽À´Ï´Ù.


5. »óºÎ À§Àå°ü¿¡¼­ÀÇ À̹°Áú (¼º°¡·Ñ·Îº´¿ø ¹Úâ±¹ °úÀå´Ô)

´Ù¿î ÁõÈıº ȯÀÚ°¡ 6 ¹ÌÅÍ ±æÀÌÀÇ plastic wire¸¦ ¸Ô¾ú´Âµ¥ ¿©·¯ ³»½Ã°æ µµ±¸·Î À߶óÁöÁö ¾Ê¾Ò½À´Ï´Ù. APC¸¦ »ç¿ëÇÏ¿© plastic wire¸¦ ³ì¿©¼­ ²÷À» ¼ö ÀÖ¾ú°í, °á±¹ ³»½Ã°æÀ¸·Î Á¦°ÅÇÒ ¼ö ÀÖ¾ú´Ù°í ÇÕ´Ï´Ù. Subtotal gastrectomy ÈÄ ½ÊÀÌÁöÀå¿¡ ¹ÚÈù bezoar¸¦ two channel endoscope¿Í balloonÀ¸·Î À§·Î ²¨³¾ ¼ö ÀÖ¾ú´Ù°í ÇÕ´Ï´Ù. À̹° Á¦°Å¼ú¿¡´Â Ç×»ó ÀÇ»çÀÇ »ó»ó·ÂÀÌ Áß¿äÇÏ´Ù´Â °ÍÀ» ´Ù½Ã Çѹø ´À²¼½À´Ï´Ù.


[2015-6-19] ÀÏÀü¿¡ ¼øõ¸¸ ³»½Ã°æ ½ÉÆ÷Áö¾ö¿¡¼­ ¼Ò°³µÇ¾ú´ø ¼º°¡·Ñ·Îº´¿ø À§ À̹° Áõ·Ê°¡ ´ëÇÑ»óºÎÀ§Àå°üÇ︮ÄÚ¹ÚÅÍ ÇÐȸÁö 2015³â 2È£¿¡ ½Ç·Á¼­ »çÁøÀ» ¼Ò°³ÇÕ´Ï´Ù. ´Ù½Ã ºÁµµ ´ë´ÜÇÕ´Ï´Ù. ¼±»ý´Ô. ¼ö°í ¸¹À¸¼Ì½À´Ï´Ù.


6. °æºñ³»½Ã°æ (À§¾ØÀå¼­³»°ú ¼­Á¾¿Á ¿øÀå´Ô)

À§¾ØÀå¼­³»°ú ¼­Á¾¿Á ¿øÀå´ÔÀº °æºñ³»½Ã°æ ÈÄ ÄÚÇÇ¿¡ ´ëÇÏ¿© ¹ßÇ¥Çϼ̽À´Ï´Ù. 18,037¿¹ÀÇ °æºñ³»½Ã°æ ¼º°ø·üÀº 97.6%¿´°í (°æ±¸ÀüȯÀ² 2.4%), ºñÃâÇ÷·üÀº 7.3%¿´½À´Ï´Ù.


[Âü°íÀÚ·á]

1) ¼øõ¸¸³»½Ã°æ¼¼¹Ì³ª

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà